An optimized derivative of an endogenous CXCR4 antagonist prevents atopic dermatitis and airway inflammation

Authors:

Abstract
No abstract available
All Related Versions
Funding Information
  • Deutsche Forschungsgemeinschaft (CRC1279, MU 3115, MU 3115/11-1)
  • Boehringer Ingelheim Stiftung
  • Baden-Württemberg Stiftung (EXC 2033–390677874)

This publication has 59 references indexed in Scilit: